Exercise-Induced Bronchoconstriction: A Type of Asthma Triggered by Physical Activity
Exercise-induced bronchoconstriction (EIB) is the preferred term for the transient narrowing of the lower airway that occurs after exercise, which can affect individuals with or without underlying asthma. 1, 2
Definition and Pathophysiology
- EIB is characterized by airway narrowing that occurs during or after physical exertion, not a separate type of asthma but rather a trigger for bronchoconstriction 2
- The term "exercise-induced bronchoconstriction" is preferred over "exercise-induced asthma" (EIA) as it doesn't imply that exercise causes asthma but rather triggers or exacerbates symptoms 1
- EIB is triggered by the loss of water in bringing large volumes of air to body conditions in a short time during exercise 1
- The mechanisms involve thermal (cooling and rewarming) and/or osmotic effects of airway dehydration 1
- Increased osmolarity stimulates mast cell degranulation, leading to the release of inflammatory mediators such as histamine, tryptase, and leukotrienes 2
Clinical Presentation
- Symptoms typically develop 5-10 minutes after exercise, peak 8-15 minutes post-exercise, and resolve within 30-90 minutes without treatment 2, 3
- Common symptoms include chest tightness, cough, wheezing, and shortness of breath 2, 4
- A refractory period of up to 3 hours after recovery may occur, during which repeat exercise causes less bronchospasm 3
- Symptoms can range from mild to severe, with most cases being mild to moderate but potentially impairing athletic performance 2
Prevalence
- EIB occurs in approximately 90% of patients with asthma and up to 40% of patients with allergic rhinitis 4
- The prevalence in the general population is estimated between 6-13% 4
- Elite athletes have a higher prevalence (30-70%) than the general population 2
- Specific sports carry higher risk due to environmental exposures:
Diagnosis
- Diagnosis of EIB should be confirmed by demonstration of airways reversibility or challenge testing, as self-reported symptoms are not reliable for diagnosis 1, 2
- A positive diagnosis requires a decrease in FEV1 of ≥10% after exercise and symptoms consistent with bronchospasm 2
- Exercise challenge testing should ensure ventilation reaches at least 60% of maximum voluntary ventilation using dry air 1
- Alternative testing methods include:
Management
Pharmacologic Treatment
- First-line treatment: Short-acting β2-agonists (SABAs) 15 minutes before exercise, providing protection in 80-95% of affected individuals 2, 4
- For persistent symptoms despite pre-exercise SABA:
- Mast cell stabilizing agents (cromolyn sodium or nedocromil) may be used before exercise 2, 4
- Avoid daily use of long-acting β2-agonists (LABAs) as monotherapy due to risk of side effects and tolerance development 2
Non-Pharmacologic Approaches
- Warm-up exercise before planned activity can help prevent EIB 2, 3
- Use of a face mask or scarf to warm and humidify air during cold weather exercise 2, 3
- Dietary modifications that may help include:
- Low-salt diet
- Fish oil supplementation
- Vitamin C supplementation 2
- Avoid known triggers and high-pollution environments 2
- Choose sports with lower minute ventilation when possible 2, 5
Important Clinical Considerations
- EIB in asthmatic patients can indicate poor control of underlying asthma and suggests the need to initiate or step up therapy 1
- Approximately 9% of individuals with EIB have no history of asthma or allergy 4
- If symptoms persist despite appropriate treatment, consider alternative diagnoses such as cardiac conditions, other pulmonary disorders, vocal cord dysfunction, or anxiety 5
- The severity of EIB is related to the level of ventilation, heat and water loss from the respiratory tree, and the rate of airway rewarming and rehydration after exercise 4